The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
The complement system: History, pathways, cascade and inhibitors
Open accessAbstract
Since its discovery in the 19th century, the complement system has developed into a clinically significant entity. The complement system has been implicated in a variety of clinical conditions, from autoimmune diseases to ischemia-reperfusion injury in transplantation. This article charts the historical progress of our understanding of the complement system and provides a synopsis on the activation pathways and its inherent regulators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Wiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,149
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441506 · Cited by 1,481
Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W., & Wardlaw, A. C. (1954) · Science · doi:10.1126/science.120.3112.279 · Cited by 938
Complement-dependent Clearance of Apoptotic Cells by Human Macrophages
Mevorach, D., Mascarenhas, J. O., Gershov, D., & Elkon, K. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2313 · Cited by 700
Davies, A., Simmons, D. L., Hale, G., Harrison, R. A., Tighe, H., Lachmann, P. J., & Waldmann, H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.637 · Cited by 633
Complement: a unique innate immune sensor for danger signals
GASQUE, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.011 · Cited by 552
Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldmann, H., & Lachmann, P. J. (1990) · PubMed Central · Cited by 533
Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase
Bokisch, V. A., & Müller-Eberhard, H. J. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106462 · Cited by 517
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
Chenoweth, D. E., & Hugli, T. E. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3943 · Cited by 509
Griselli, M., Herbert, J., Hutchinson, W. L., Taylor, K. M., Sohail, M., Krausz, T., & Pepys, M. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1733 · Cited by 508
Decay-Accelerating Factor: Biochemistry, Molecular Biology, And Function
Lublin, D. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.35 · Cited by 496
ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION
Super, M., Lu, J., Thiel, S., Levinsky, R. T., & Turner, M. W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91849-7 · Cited by 493
Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
C5a-induced expression of P-selectin in endothelial cells.
Foreman, K. E., Vaporciyan, A. A., Bonish, B. K., Jones, M. L., Johnson, K. J., Glovsky, M. M., Eddy, S. M., & Ward, P. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117430 · Cited by 473
Interaction Between the Coagulation and Complement System
Amara, U., Rittirsch, D., Flierl, M., Bruckner, U., Klos, A., Gebhard, F., Lambris, J. D., & Huber-Lang, M. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-78952-1_6 · Cited by 471
Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)
Ahearn, J. M., & Fearon, D. T. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60654-9 · Cited by 448
The Central Role of the Alternative Complement Pathway in Human Disease
Thurman, J. M., & Holers, V. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1305 · Cited by 432
Complement control protein factor H: The good, the bad, and the inadequate
Ferreira, V. P., Pangburn, M. K., & Cortés, C. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.007 · Cited by 420
Nilsson, U. R., & Müller-Eberhard, H. J. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.2.277 · Cited by 412
Dahl, M. R., Thiel, S., Matsushita, M., Fujita, T., Willis, A. C., Christensen, T., Vorup-Jensen, T., & Jensenius, J. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00161-3 · Cited by 397
The Role of Complement and Its Receptor in the Elimination of Immune Complexes
Epstein, F. H., Schifferli, J. A., Ng, Y. C., & Peters, D. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608213150805 · Cited by 396
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects
Morgan, B. P. (1989) · Biochemical Journal · doi:10.1042/bj2640001 · Cited by 380
THE PROPERDIN SYSTEM AND IMMUNITY
Pillemer, L., Blum, L., Lepow, I. H., Wurz, L., & Todd, E. W. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.1.1 · Cited by 354
THE ROLE OF THE COMPLEMENT SYSTEM IN ISCHEMIA-REPERFUSION INJURY
Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Granger, D. N., & Taylor, S. M. (2004) · Shock · doi:10.1097/00024382-200405000-00002 · Cited by 327
Isolation and characterization of a mannan-binding protein from rabbit serum
Kozutsumi, Y., Kawasaki, T., & Yamashina, I. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)90836-0 · Cited by 323
Membrane attack by complement: the assembly and biology of terminal complement complexes
Tegla, C. A., Cudrici, C., Patel, S., Trippe, R., Rus, V., Niculescu, F., & Rus, H. (2011) · Immunologic Research · doi:10.1007/s12026-011-8239-5 · Cited by 321
Proteolytic Activities of Two Types of Mannose-Binding Lectin-Associated Serine Protease
Matsushita, M., Thiel, S., Jensenius, J. C., Terai, I., & Fujita, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2637 · Cited by 318
Kaufmann, S. H. E. (2008) · Nature Immunology · doi:10.1038/ni0708-705 · Cited by 292
C5a Induces Tissue Factor Activity on Endothelial Cells
Ikeda, K., Nagasawa, K., Horiuchi, T., Tsuru, T., Nishizaka, H., & Niho, Y. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655974 · Cited by 272
Structure and function of the anaphylatoxins
Hugh, T. E. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893020 · Cited by 259
Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils
de Vries, B., Köhl, J., Leclercq, W. K. G., Wolfs, T. G. A. M., van Bijnen, A. A. J. H. M., Heeringa, P., & Buurman, W. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3883 · Cited by 246
Complement deficiency states and associated infections
Skattum, L., van Deuren, M., van der Poll, T., & Truedsson, L. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.05.001 · Cited by 240
ANTIMICROBIAL FACTORS OF NORMAL TISSUES AND FLUIDS
Skarnes, R. C., & Watson, D. W. (1957) · Bacteriological Reviews · doi:10.1128/br.21.4.273-294.1957 · Cited by 232
The role of complement in inflammation and adaptive immunity
Barrington, R., Zhang, M., Fischer, M., & Carroll, M. C. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800101.x · Cited by 232
Ehrnthaller, C., Ignatius, A., Gebhard, F., & Huber-Lang, M. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00149 · Cited by 226
Regulation of the Complement Membrane Attack Pathway
Morgan, B. P. (1999) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v19.i3.10 · Cited by 222
Isolation and characterization of a mannan-binding protein from rabbit liver
Kawasaki, T., Etoh, R., & Yamashina, I. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91452-3 · Cited by 216
Generation of C5a by Phagocytic Cells
Huber-Lang, M., Younkin, E. M., Sarma, J. V., Riedemann, N., McGuire, S. R., Lu, K. T., Kunkel, R., Younger, J. G., Zetoune, F. S., & Ward, P. A. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64461-6 · Cited by 212
Hansen, S., Selman, L., Palaniyar, N., Ziegler, K., Brandt, J., Kliem, A., Jonasson, M., Skjoedt, M.-O., Nielsen, O., Hartshorn, K., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002185 · Cited by 204
Ficolins and the lectin complement pathway
Matsushita, M., & Fujita, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800107.x · Cited by 203
Vorup-Jensen, T., Petersen, S. V., Hansen, A. G., Poulsen, K., Schwaeble, W., Sim, R. B., Reid, K. B. M., Davis, S. J., Thiel, S., & Jensenius, J. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2093 · Cited by 202
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT
Müller‐Eberhard, H. J., & Biro, C. E. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.3.447 · Cited by 191
Carboxypeptidase N: a pleiotropic regulator of inflammation
Matthews, K. W., Mueller-Ortiz, S. L., & Wetsel, R. A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.002 · Cited by 185
C5a-Induced Gene Expression in Human Umbilical Vein Endothelial Cells
Albrecht, E. A., Chinnaiyan, A. M., Varambally, S., Kumar-Sinha, C., Barrette, T. R., Sarma, J. V., & Ward, P. A. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63173-2 · Cited by 178
ROLE OF THE ALTERNATIVE PATHWAY IN THE EARLY COMPLEMENT ACTIVATION FOLLOWING MAJOR TRAUMA
Ganter, M. T., Brohi, K., Cohen, M. J., Shaffer, L. A., Walsh, M. C., Stahl, G. L., & Pittet, J.-F. (2007) · Shock · doi:10.1097/shk.0b013e3180342439 · Cited by 171
Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.
Koski, C. L., Ramm, L. E., Hammer, C. H., Mayer, M. M., & Shin, M. L. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3816 · Cited by 165
Biochemistry and Biology of Anaphylatoxins
Hugli, T. E. (1986) · Complement · doi:10.1159/000467889 · Cited by 163
Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases
Miwa, T., & Song, W.-C. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00043-6 · Cited by 160
Role for the Alternative Complement Pathway in Ischemia/Reperfusion Injury
Stahl, G. L., Xu, Y., Hao, L., Miller, M., Buras, J. A., Fung, M., & Zhao, H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63839-4 · Cited by 160
Complement-Mediated Ischemia-Reperfusion Injury
Diepenhorst, G. M. P., van Gulik, T. M., & Hack, C. E. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a38f45 · Cited by 159
The Biological Functions of MBL-Associated Serine Proteases (MASPs)
Hajela, K. (2002) · Immunobiology · doi:10.1078/0171-2985-00147 · Cited by 150
Li, B., Sallee, C., Dehoff, M. H., Foley, S. F., Molina, H. D., & Holers, V. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4295 · Cited by 141
Complement regulatory proteins in glomerular diseases
Nangaku, M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00130.x · Cited by 133
Complement mediators in ischemia–reperfusion injury
Arumugam, T. V., Magnus, T. U., Woodruff, T. M., Proctor, L. M., Shiels, I. A., & Taylor, S. M. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.06.010 · Cited by 132
Complement and innate immunity
Song, W.-C., Sarrias, M., & Lambris, J. D. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80303-3 · Cited by 129
CD46 in innate and adaptive immunity: an update
Cardone, J., Friec, G. L., & Kemper, C. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04400.x · Cited by 104
Complement: Clinical Aspects and Relevance to Disease
Morgan, B. P. (1991) · Cited by 96
Damman, J. J., Daha, M. R., van Son, W. J., Leuvenink, H. G. D., Ploeg, R. J., & Seelen, M. A. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03475.x · Cited by 96
The new face of anaphylatoxins in immune regulation
Zhou, W. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.016 · Cited by 94
Biological effects of C1 inhibitor
Davis, A. E. (2004) · Drug News & Perspectives · doi:10.1358/dnp.2004.17.7.863703 · Cited by 93
Complement deficiency and immune complex disease
Davies, K. A., Schifferli, J. A., & Walport, M. J. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf01837367 · Cited by 92
Complement factor H and the hemolytic uremic syndrome
Atkinson, J. P., & Goodship, T. H. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070664 · Cited by 85
Effect of interferon-γ on complement gene expression in different cell types
Lappin, D. F., Guc, D., Hill, A., McShane, T., & Whaley, K. (1992) · Biochemical Journal · doi:10.1042/bj2810437 · Cited by 83
Activation of the lectin complement pathway by ficolins
Matsushita, M., Endo, Y., Hamasaki, N., & Fujita, T. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00045-x · Cited by 82
The first component of human complement (C1): Activation and control
Ziccardi, R. J. (1983) · Springer Seminars in Immunopathology · doi:10.1007/bf00205874 · Cited by 80
Complement: Clinical aspects and relevance to disease
Ross, G. D. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90045-u · Cited by 79
The Role of C5b-9 Terminal Complement Complex in Activation of the Cell Cycle and Transcription
Fosbrink, M. D., Niculescu, F. I., & Rus, H. (2004) · Immunologic Research · doi:10.1385/ir:31:1:37 · Cited by 79
Role of complement and perspectives for intervention in ischemia-reperfusion damage
Banz, Y., & Rieben, R. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.535556 · Cited by 75
Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator
Skidgel, R. A., & Erdös, E. G. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.07.014 · Cited by 72
Miwa, T., Nonaka, M. I., Okada, N., Wakana, S., Shiroishi, T., & Okada, H. (1998) · Immunogenetics · doi:10.1007/s002510050447 · Cited by 70
Gavrilyuk, V., Kalinin, S., Hilbush, B. S., Middlecamp, A., McGuire, S. O., Pelligrino, D. A., Weinberg, G. L., & Feinstein, D. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02942.x · Cited by 69
THE EIGHTH COMPONENT OF HUMAN COMPLEMENT (C8): ISOLATION, CHARACTERIZATION, AND HEMOLYTIC EFFICIENCY
Manni, J. A., & Müller‐Eberhard, H. J. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.5.1145 · Cited by 62
The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury
Fondevila, C., Shen, X., Tsuchihashi, S.-I., Uchida, Y., Freitas, M. C. S., Ke, B., Busuttil, R. W., & Kupiec‐Weglinski, J. W. (2008) · Liver Transplantation · doi:10.1002/lt.21496 · Cited by 59
Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex
Austen, W. G., Kyriakides, C., Favuzza, J., Wang, Y., Kobzik, L., Moore, F. D., & Hechtman, H. B. (1999) · Surgery · doi:10.1016/s0039-6060(99)70175-3 · Cited by 58
SECTION OF BIOLOGY: THE PROPERDIN SYSTEM*
Pillemer, L. (1955) · Transactions of the New York Academy of Sciences · doi:10.1111/j.2164-0947.1955.tb02817.x · Cited by 57
Lappin, D. F., & Whaley, K. (1990) · Biochemical Journal · doi:10.1042/bj2710767 · Cited by 49
Transcriptional control of genes for soluble complement cascade regulatory proteins
Fraczek, L., & Martin, B. K. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.08.016 · Cited by 37
Mayer, M. M., Miller, J. A., & Shin, H. S. (1970) · The Journal of Immunology · doi:10.4049/jimmunol.105.2.327 · Cited by 28
Tauber, A. I., & Chernyak, L. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90043-9 · Cited by 26
Minta, J. O., Fung, M., Turner, S., Eren, R., Zemach, L., Rits, M., & Goldberger, G. (1998) · Gene · doi:10.1016/s0378-1119(97)00632-x · Cited by 21
Lectin Activity of the Coagulation Factor VIII/von Willebrand Complex
Santizo, F., Zenteno, E., Pina-Canseco, M. D. S., Cruz, P. A. H., Cruz, M. M., Mayoral, L. P.-C., Pérez‐Campos, E., & Martínez-Cruz, R. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.217.209 · Cited by 5
Cited by
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Gralinski, L. E., Sheahan, T. P., Morrison, T. E., Menachery, V. D., Jensen, K., Leist, S. R., Whitmore, A., Heise, M. T., & Baric, R. S. (2018) · mBio · doi:10.1128/mbio.01753-18 · Cited by 655
The associations of cerebrospinal fluid ApoE and C1q with Alzheimer's disease biomarkers
Lin, Y.-J., Liu, Y., Sheng, Z.-H., Fu, Y., Ma, L.-Z., Zhang, Z.-H., Wang, L.-Y., Huang, L.-Y., Liu, M., Wang, Z.-T., et al. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251320419 · Cited by 3
Metadata
- Authors
- Nesargikar, P., Spiller, B., & Chavez, R.
- Venue
- European Journal of Microbiology and Immunology
- Publisher
- Akademiai Kiado Zrt.
- Published
- 2012-06
- Volume
- 2
- Issue
- 2
- Pages
- 103-111
- ISSN
- 2062-509X (ISSN-L)
- 2062-8633
- OpenAlex
- W2077888633
- Cited by
- 324
- References
- 82
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.